Replies to post #8989 on FDA Plays

[pcrutch]

as Jason Napodano said, "What's a potential blockbuster? -052? In phase 2a?!?! Get serious. The drug is 5-6 years and $200 million from approval! "

enough said. as we saw with CYTK, Phase 2A doesnt mean much. Also, $XOMA has probably the worst management out there, next to $CTIC and $GNBT